-
A large outbreak of community acquired pneumonia due to macrolide-resistant M. pneumoniae (MRMP) occurred in Japan in 2011 and mainly affected school-age children.
-
In this issue: Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.
-
The relationship between neurologic complications of infective endocarditis (IE), urgent valve surgery, and outcomes is poorly understood. Thus, these investigators performed a retrospective analysis of a prospectively collected database of IE cases from 1984-2009 in seven Spanish hospitals.
-
-
Dolutegravir, a once daily hiv-1 integrase strand transfer inhibitor (INSTI), has been approved by the FDA.
-
Fluoroquinolones are commonly prescribed bactericidal agents with a wide spectrum of activity. In addition to the coverage against conventional gram-negative organisms, newer agents in this class have an expanded spectrum of activity against a variety of gram-positive and atypical organisms.
-
This cross-sectional studys purpose was to validate the Male Osteoporosis Risk Estimation Score (MORES) in a primary care setting; it had been previously validated in the National Health and Nutrition Examination Survey (NHANES) III.
-
Our Newest Pharmacologic Class for Treatment of Diabetes: SGLT2 Inhibitors
-
Insomnia is a common complaint among adults and it is well recognized that mental performance can be impaired by poor sleep. Both difficulty falling asleep and trouble staying asleep have been associated with poor cognitive function in cross-sectional elderly cohorts.
-